• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Financial Services·HBLN.SW
Share

Hypothekarbank Lenzburg AG Stocks

CHF 4200Last Updated 22.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

CHF 366.21M

CHF 4200
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hypothekarbank Lenzburg AG is a Swiss financial institution that delivers a broad spectrum of banking and financial solutions. Serving both individual clients and businesses across Switzerland, its offerings encompass savings accounts, real estate financing and mortgage services, a range of payment cards (credit, debit, and travel), investment opportunities, pension products, tailored financial planning, and tax assistance. The bank maintains a physical presence through 13 branches and 2 advisory offices, strategically located across 12 municipalities within the Aargau canton. Established in 1868, its corporate headquarters are situated in Lenzburg, Switzerland.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E. Editor's note: P

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.10.2026 20:18

Not all AI stocks are equally resilient: Morgan Stanley has selected 24 favorites

23.10.2026 19:28

Apple surpassed Nvidia during trading and became the world's most valuable company

23.10.2026 18:44

U.S. equities slide at the open on Friday as Brent crude tops $115

23.10.2026 18:36

Jensen Huang: “Today, I’m even more enthusiastic about AI than I was a year ago.”

23.10.2026 17:55

Biohaven soars 25% as drug moves closer to approval. Is there more upside?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026